ANNX peer analysis
Annexon (ANNX) against its competitors: price, today's move, 1-year return and market value side by side.
ANNX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABVX Abivax | $85.75 | 1.87% | -13.91% | $7.51B |
| ACIU AC Immune | $2.11 | -7.86% | -38.48% | $214.74M |
| ACRS Aclaris Therapeutics | $3.90 | 8.03% | 59.73% | $504.77M |
| ALMS Alumis | $6.03 | 3.08% | 31.51% | – |
| ANAB AnaptysBio | $45.80 | 0.48% | 29.08% | $1.39B |
| IFRX InflaRx | $1.30 | -3.69% | 5.24% | $19.43M |
| IMVT Immunovant | $29.10 | 2.50% | 29.24% | $6.30B |
| PRTA Prothena | $7.97 | 1.01% | -22.30% | $417.78M |
| QTTB Q32 Bio | $9.25 | 4.52% | 287.45% | – |
| XNCR Xencor | $35.82 | 5.20% | 148.92% | $2.66B |
| ANNX Annexon | $4.20 | 4.87% | 39.37% | – |
- ANNX's peers: ABVX (Abivax), ACIU (AC Immune), ACRS (Aclaris Therapeutics), ALMS (Alumis), ANAB (AnaptysBio), IFRX (InflaRx), IMVT (Immunovant), PRTA (Prothena).
Updated 2026-11-07 11:53 UTC